Board Leadership

LSC    About

FILTER BY

Amanda  Banks

Amanda Banks

Former CEO, Co-Founder

Blackfynn

Scott Bechtler-Levin

Scott Bechtler-Levin

Head of Venture Design

Redesign Health

Terry-Ann Burrell

Terry-Ann Burrell

CFO

Beam Therapeutics

Carin  Canale-Theakston

Carin Canale-Theakston

CEO and Founder

Evoke Canale

Abe Ceesay

Abe Ceesay

CEO

Rapport Therapeutics

Chip Clark

Chip Clark

Entrepreneur in Residence

SROne Capital Management

Thomas Daniel

Thomas Daniel

Chairman, Board of Overseers & Director

The Scripps Research Institute

Michael Dougherty

Michael Dougherty

Biopharmaceutical Executive & Board Member

Cindy Dunkle

Cindy Dunkle

Chief People Officer

Denali

Jonathan Fassberg
Wainwright Fishburn

Wainwright Fishburn

Partner, Global Head of Digital Health

Cooley LLP

Jennifer Fox

Jennifer Fox

Chief Business Officer and Chief Financial Officer

Zenas BioPharma

Carol G. Gallagher, Pharm.D.

Carol G. Gallagher, Pharm.D.

Venture Partner

New Enterprise Associates

George Golumbeski

George Golumbeski

Partner

Droia Ventures

Faheem Hasnain

Faheem Hasnain

Chairman & co-founder

Gossamer Bio Chairman of Mirati, Aspen Neuroscience & Sente Inc. Lead Director, Kura Oncology

Jeff Hessekiel

Jeff Hessekiel

EVP & General Counsel

Exelixis

Richard Heyman

Richard Heyman

Vice Chairman of the
Board of Trustees

Salk Institute for Biological Studies

Jeb Keiper

Jeb Keiper

CEO

Nimbus Therapeutics

Nina Kjellson

Nina Kjellson

President & CEO

Canaan

Peter Lafer

Peter Lafer

Principal, Life Sciences

General Atlantic

Ted Love

Ted Love

President & CEO

Global Blood Therapeutics

John Maraganore

John Maraganore

Founding CEO (Former)

Alnylam

Cynthia Mazareas

Cynthia Mazareas

Partner

WilmerHale

Mark McClung

Mark McClung

Executive Vice President and Chief Operating Officer

Sangamo

David Melville

David Melville

CEO

The Bowdoin Group

Vin Milano

Vin Milano

Former CEO

Idera Pharmaceuticals

Patricia  Millican

Patricia Millican

Life Science Strategic Advisor

Patricia Millican

Patricia Millican

Chief Financial Officer

Architect Therapeutics

Shawnte Mitchell

Shawnte Mitchell

EVP & General Counsel

Zogenix

Chris Molineaux

Chris Molineaux

President and CEO

Life Sciences Pennsylvania

Jodie Morrison

Jodie Morrison

CEO

Q32 Bio

Matt Outten

Matt Outten

CCO

Bridge Bio

Deb Palestrant

Deb Palestrant

Partner & Executive Chair, 459 Intitiative

5AM Ventures

Rob Perez

Rob Perez

Operating Partner

General Atlantic

Dennis Purcell

Dennis Purcell

Founder and Senior Advisor

Aisling Capital

Jim Reddoch

Jim Reddoch

EVP Investments and CSO

Royalty Pharma

Kristin Reed

Kristin Reed

Executive Director

Genentech Foundation

Felicia Rinier

Felicia Rinier

Executive Director

GreenLight Fund Philadelphia

Rene Russo

Rene Russo

CEO

Xilio Therapeutics

Katherine Scangos

Katherine Scangos

University of California, San Francisco

Lynn Seely

Lynn Seely

Former President & CEO

Myovant

Mike Tomsicek

Mike Tomsicek

Chief Financial Officer (Former)

CRISPR Therapeutics

Nolan Townsend

Nolan Townsend

CEO

LEXEO Therapeutics

Robert Urban

Robert Urban

Global Head of Innovation (Former/Retired)

J&J Innovation

Kate Wilson

Kate Wilson

President

Gilead Foundation

Lily Wound

Lily Wound

Partner

DLA Piper

Load More